Replies to post #198019 on Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

Actually that logic is not wrong - he is adding $30 million now at much lower price - he could have added 30 million then pushed the ABSSI which would have shown good progress of enrollment like p2 and supported the price above $1 - he could have added the same $5-6 million more to keep on running other indications as he runs today.

So dilution is happening anyway - but without concrete progress on ABSSI which is the best confirmed results of of the indications. That is screw up

For otc biotechs - upto 200 million o/s shares is kind of norm - no big deal